China monoclonal antibodies market is estimated to grow at a CAGR of 9.2% during the forecast period. A significant rise in cancer incidences and increasing launches of biosimilars are some potential factors accelerating market growth.
Please read the originial post here: https://www.omrglobal.com/industry-reports/china-monoclonal-antibodies-market
